Elantas Beck India Ltd vs Saroja Pharma Industries India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

The Latest Trading Price of Elantas Beck India Ltd is ₹ 7582 as of 18 Mar 15:30 . The p/e ratio of Elantas Beck India Ltd changed from 43.6 to 0 over 9 quarters. This represents a CAGR of -100.00% The p/e ratio of Saroja Pharma Industries India Ltd changed from 16.1 to 14.7 over 2 quarters. This represents a CAGR of -16.64% The market cap of Elantas Beck India Ltd changed from ₹ 2913 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The market cap of Saroja Pharma Industries India Ltd changed from ₹ 14.11 crore to ₹ 15.18 crore over 2 quarters. This represents a CAGR of 15.74% The revenue of Elantas Beck India Ltd for the Mar '25 is ₹ 229.03 crore as compare to the Dec '25 revenue of ₹ 223.74 crore. This represent the growth of 2.36% The revenue of Saroja Pharma Industries India Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Elantas Beck India Ltd for the Mar '25 is ₹ 58.81 crore as compare to the Dec '25 ebitda of ₹ 54.38 crore. This represent the growth of 8.15% The ebitda of Saroja Pharma Industries India Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Elantas Beck India Ltd changed from ₹ 36.91 crore to ₹ 39.37 crore over 7 quarters. This represents a CAGR of 3.76% The net profit of Saroja Pharma Industries India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The dividend payout of Elantas Beck India Ltd changed from 5.93 % to 0 % over 9 quarters. This represents a CAGR of -100.00% The dividend payout of Saroja Pharma Industries India Ltd changed from 0 % to 0 % over 9 quarters. This represents a CAGR of 0.0% .

About Elantas Beck India Ltd

Elantas Beck India Limited, formerly known as Beck India Limited, incorporated on March 15, 1956 is a subsidiary of Elantas GmbH Company based in Germany.
Elantas GmbH is part of Altana Group whose Ultimate Holding Company is SKion GmbH. The Company changed the name from Beck India Limited to Elantas Beck India Limited on June 19, 2007.
At present, Company manufactures specialty chemicals for electrical insulation and construction industries.
It has manufacturing plants at Pimpri and Ankleshwar in India. The Company was promoted by Mahindra & Mahindra in collaboration with Dr Beck & Company, Germany.
It went public in 1961.

About Saroja Pharma Industries India Ltd

Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.

FAQs for the comparison of Elantas Beck India Ltd and Saroja Pharma Industries India Ltd

Which company has a larger market capitalization, Elantas Beck India Ltd or Saroja Pharma Industries India Ltd?

Market cap of Elantas Beck India Ltd is 6,011 Cr while Market cap of Saroja Pharma Industries India Ltd is 12 Cr

What are the key factors driving the stock performance of Elantas Beck India Ltd and Saroja Pharma Industries India Ltd?

The stock performance of Elantas Beck India Ltd and Saroja Pharma Industries India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Elantas Beck India Ltd and Saroja Pharma Industries India Ltd?

As of March 18, 2026, the Elantas Beck India Ltd stock price is INR ₹7582.3. On the other hand, Saroja Pharma Industries India Ltd stock price is INR ₹31.15.

How do dividend payouts of Elantas Beck India Ltd and Saroja Pharma Industries India Ltd compare?

To compare the dividend payouts of Elantas Beck India Ltd and Saroja Pharma Industries India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.